FGL1 and injury: These findings agree with previous reports claiming an important role of HPS in rats’ liver injury models [5], and highlight HPS delivery may be a potential therapeutic strategy for the treatment of acute liver injury in humans, mostly in patients who would need long-term treatment with potentially hepatotoxic drugs.